ACHIEVE A RICHER LIFE
THROUGH HEARING
AND HEALTH
ACHIEVE A RICHER LIFE
THROUGH HEARING
AND HEALTH
ABOUT
ABOUT
As the global population continues to age, hearing loss has become an important social issue, as it can contribute to dementia and social isolation.
However, effective treatments are not available for many forms of hearing loss, and fundamental treatment remains difficult.
We are working to develop gene therapy for GJB2-related hereditary hearing loss, the most common form of genetic hearing loss worldwide.
PIPELINE
PIPELINE
Researchers at Juntendo University have identified that one of the major causes of hereditary hearing loss is abnormalities in a molecule called gap junction in inner ear cells. Based on this discovery, they are developing new biopharmaceuticals using iPS cell technology and genetic biotechnology.
Gap Junction Therapeutics, Inc. builds on these technologies to advance the research and development of pharmaceuticals and supplements aimed at the fundamental treatment and prevention of hearing loss and other gap junction-related diseases.
NEWS
-
mediaHokkaido University Launches Joint Research on Gap Junction–Based Drug Discovery for Age-Related and Genetic Hearing Loss — Nikkei Biotech
-
infoHearing Loss Gene Repaired with Therapeutic Drug in Mice, New Method Succeeds — Asahi Shimbun
-
mediaJuntendo University Develops Genome Editing Therapy for Hereditary Hearing Loss — Nikkei
-
pressResearchers Develop Genome Editing Technology for Hereditary Hearing Loss — Press Release
-
mediaTakara Bio Partners with Startup to Develop In Vivo Gene Therapy for Genetic Hearing Loss — Nikkei Biotech
CONTACT US
If you have any questions or inquiries regarding our services,
please feel free to contact us through our contact page.
CONTACT US
If you have any questions or inquiries regarding our services,
please feel free to contact us through our contact page.
If you have any questions or inquiries regarding our services,
please feel free to contact us through our contact page.